HCP, Inc. (NYSE:HCP) updated its FY17 earnings guidance on Tuesday. The company provided EPS guidance of $1.89-1.95 for the period, compared to the Thomson Reuters consensus EPS estimate of $1.94.
A number of equities research analysts have issued reports on the company. UBS AG upgraded HCP from an underperform rating to an outperform rating in a research note on Wednesday, June 14th. Goldman Sachs Group, Inc. (The) cut HCP from a buy rating to a neutral rating and lowered their price target for the stock from $35.00 to $32.00 in a report on Monday, July 24th. Stifel Nicolaus reaffirmed a hold rating and set a $31.00 price objective on shares of HCP in a report on Friday, July 14th. BidaskClub raised HCP from a hold rating to a buy rating in a report on Wednesday, June 21st. Finally, Mizuho reissued a neutral rating on shares of HCP in a research report on Wednesday, June 28th. Three investment analysts have rated the stock with a sell rating, fifteen have given a hold rating and three have given a buy rating to the company. HCP currently has an average rating of Hold and a consensus target price of $33.42.
Shares of HCP, Inc. (NYSE:HCP) opened at 28.85 on Friday. HCP, Inc. has a one year low of $27.61 and a one year high of $40.43. The firm has a market capitalization of $13.53 billion, a price-to-earnings ratio of 19.67 and a beta of 0.37. The firm has a 50-day moving average price of $30.83 and a 200 day moving average price of $31.23.
The firm also recently announced a quarterly dividend, which will be paid on Tuesday, August 22nd. Shareholders of record on Monday, August 7th will be issued a $0.37 dividend. The ex-dividend date of this dividend is Thursday, August 3rd. This represents a $1.48 dividend on an annualized basis and a yield of 5.13%. HCP’s dividend payout ratio is currently 102.07%.
In other news, insider Thomas Klaritch sold 2,651 shares of HCP stock in a transaction that occurred on Tuesday, June 13th. The stock was sold at an average price of $31.53, for a total transaction of $83,586.03. Following the sale, the insider now owns 176,830 shares of the company’s stock, valued at $5,575,449.90. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Insiders own 0.22% of the company’s stock.
WARNING: This piece of content was originally reported by Community Financial News and is the sole property of of Community Financial News. If you are reading this piece of content on another site, it was illegally stolen and republished in violation of US and international copyright legislation. The correct version of this piece of content can be read at https://www.com-unik.info/2017/08/19/hcp-inc-nysehcp-updates-fy17-earnings-guidance-updated-updated.html.
HCP Company Profile
HCP, Inc is a self-administered real estate investment trust. The Company invests in real estate serving the healthcare industry in the United States. The Company’s segments include senior housing triple-net (SH NNN), senior housing operating portfolio (SHOP), life science and medical office. Its senior housing facilities include independent living facilities, assisted living facilities, memory care facilities, care homes, and continuing care retirement communities.
What are top analysts saying about HCP Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for HCP Inc. and related companies.